HIGHLIGHTS
- who: Report and collaborators from the Critical Care Medicine, Norwalk Hospital, Norwalk, USA have published the article: Review began 12/14/2022 Review ended 12/22/2022 Published 12/28/2022 u00a9 Copyright, in the Journal: (JOURNAL) of December/28,/2022
- what: Based on our literature review, ILD associated with infliximab use in IBD generally presents early after a few infusions.
SUMMARY
Infliximab is a monoclonal antibody that targets TNF alpha and is used for the treatment of moderatesevere active ulcerative colitis (UC). Although rare, there have also been case reports . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.